Your browser doesn't support javascript.
loading
Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.
Ramanayake, Saumya; Bilmon, Ian; Bishop, David; Dubosq, Ming-Celine; Blyth, Emily; Clancy, Leighton; Gottlieb, David; Micklethwaite, Kenneth.
Afiliación
  • Ramanayake S; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia.
  • Bilmon I; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia; The Department of Haematology, Westmead Hospital, Westmead, Australia; Sydney Cellular Therapies Laboratory, Pathology West, Westmead, Australia.
  • Bishop D; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia; The Department of Haematology, Westmead Hospital, Westmead, Australia.
  • Dubosq MC; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia; The Department of Haematology, Westmead Hospital, Westmead, Australia.
  • Blyth E; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia; The Department of Haematology, Westmead Hospital, Westmead, Australia; Sydney Cellular Therapies Laboratory, Pathology West, Westmead, Australia.
  • Clancy L; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia; Sydney Cellular Therapies Laboratory, Pathology West, Westmead, Australia.
  • Gottlieb D; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia; The Department of Haematology, Westmead Hospital, Westmead, Australia; Sydney Cellular Therapies Laboratory, Pathology West, Westmead, Australia.
  • Micklethwaite K; The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead, Australia; The Department of Haematology, Westmead Hospital, Westmead, Australia; Sydney Cellular Therapies Laboratory, Pathology West, Westmead, Australia. Electronic address: kenneth.micklethwaite@sydney.ed
Cytotherapy ; 17(9): 1251-67, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26212611
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos B / Receptores de Antígenos de Linfocitos T / Linfocitos T / Separación Celular / Antígenos CD19 / Traslado Adoptivo Tipo de estudio: Guideline / Health_economic_evaluation Límite: Adult / Humans / Male Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2015 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos B / Receptores de Antígenos de Linfocitos T / Linfocitos T / Separación Celular / Antígenos CD19 / Traslado Adoptivo Tipo de estudio: Guideline / Health_economic_evaluation Límite: Adult / Humans / Male Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2015 Tipo del documento: Article País de afiliación: Australia